APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Epigenetics NGS Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Epigenetics NGS Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174135300315 April 2026195 pages

Choose your research edition.

Industry ResearchEpigenetics NGS Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenetics NGS Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Epigenetics NGS Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenetics NGS Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Epigenetics NGS Service Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Epigenetics NGS Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Epigenetics NGS Service include Active Motif, Agilent, Zymo Research, Celemics, EpiGentek, GENEWIZ from Azenta, Thermo Fisher Scientific, GenomeScan and Hologic Diagenode, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Epigenetics NGS Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epigenetics NGS Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epigenetics NGS Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Epigenetics NGS Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Epigenetics NGS Service Segment by Company

Active Motif

Agilent

Zymo Research

Celemics

EpiGentek

GENEWIZ from Azenta

Thermo Fisher Scientific

GenomeScan

Hologic Diagenode

Illumina

Macrogen

Novogene

Roche Sequencing Solutions

SeqMatic

Epigenetics NGS Service Segment by Type

DNA Methylation Sequencing

Histone Modification Sequencing

3D Genome Sequencing

Others

Epigenetics NGS Service Segment by Application

Clinical Diagnostics

Basic Research

Drug Development

Agricultural Breeding

Others

Epigenetics NGS Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics NGS Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenetics NGS Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics NGS Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Epigenetics NGS Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epigenetics NGS Service industry.

Chapter 3: Detailed analysis of Epigenetics NGS Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics NGS Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epigenetics NGS Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DNA Methylation Sequencing Table 3. Key Players of Histone Modification Sequencing Table 4. Key Players of 3D Genome Sequencing Table 3. Key Players of Others Table 4. Global Epigenetics NGS Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinical Diagnostics Table 6. Key Players of Basic Research Table 7. Key Players of Drug Development Table 8. Key Players of Agricultural Breeding Table 9. Key Players of Others Table 10. Global Epigenetics NGS Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Epigenetics NGS Service Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Epigenetics NGS Service Market Share by Region (2021-2026) Table 13. Global Epigenetics NGS Service Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Epigenetics NGS Service Market Share by Region (2027-2032) Table 15. Epigenetics NGS Service Industry Trends Table 16. Epigenetics NGS Service Industry Drivers Table 17. Epigenetics NGS Service Industry Opportunities and Challenges Table 18. Epigenetics NGS Service Industry Restraints Table 19. Global Epigenetics NGS Service Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Epigenetics NGS Service Revenue Market Share by Company (2021-2026) Table 21. Global Epigenetics NGS Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Epigenetics NGS Service Key Company Head Office and Area Served Table 23. Global Epigenetics NGS Service Company, Product Type & Application Table 24. Global Epigenetics NGS Service Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Epigenetics NGS Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Epigenetics NGS Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Epigenetics NGS Service Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Epigenetics NGS Service Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Epigenetics NGS Service Revenue Market Share by Type (2021-2026) Table 31. Global Epigenetics NGS Service Revenue Market Share by Type (2027-2032) Table 32. Global Epigenetics NGS Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Epigenetics NGS Service Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Epigenetics NGS Service Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Epigenetics NGS Service Revenue Market Share by Application (2021-2026) Table 36. Global Epigenetics NGS Service Revenue Market Share by Application (2027-2032) Table 37. Active Motif Company Information Table 38. Active Motif Business Overview Table 39. Active Motif Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Active Motif Epigenetics NGS Service Product Portfolio Table 41. Active Motif Recent Development Table 42. Agilent Company Information Table 43. Agilent Business Overview Table 44. Agilent Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Agilent Epigenetics NGS Service Product Portfolio Table 46. Agilent Recent Development Table 47. Zymo Research Company Information Table 48. Zymo Research Business Overview Table 49. Zymo Research Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Zymo Research Epigenetics NGS Service Product Portfolio Table 51. Zymo Research Recent Development Table 52. Celemics Company Information Table 53. Celemics Business Overview Table 54. Celemics Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Celemics Epigenetics NGS Service Product Portfolio Table 56. Celemics Recent Development Table 57. EpiGentek Company Information Table 58. EpiGentek Business Overview Table 59. EpiGentek Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. EpiGentek Epigenetics NGS Service Product Portfolio Table 61. EpiGentek Recent Development Table 62. GENEWIZ from Azenta Company Information Table 63. GENEWIZ from Azenta Business Overview Table 64. GENEWIZ from Azenta Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio Table 66. GENEWIZ from Azenta Recent Development Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. GenomeScan Company Information Table 73. GenomeScan Business Overview Table 74. GenomeScan Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. GenomeScan Epigenetics NGS Service Product Portfolio Table 76. GenomeScan Recent Development Table 77. Hologic Diagenode Company Information Table 78. Hologic Diagenode Business Overview Table 79. Hologic Diagenode Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Hologic Diagenode Epigenetics NGS Service Product Portfolio Table 81. Hologic Diagenode Recent Development Table 82. Illumina Company Information Table 83. Illumina Business Overview Table 84. Illumina Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Illumina Epigenetics NGS Service Product Portfolio Table 86. Illumina Recent Development Table 87. Macrogen Company Information Table 88. Macrogen Business Overview Table 89. Macrogen Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Macrogen Epigenetics NGS Service Product Portfolio Table 91. Macrogen Recent Development Table 92. Novogene Company Information Table 93. Novogene Business Overview Table 94. Novogene Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Novogene Epigenetics NGS Service Product Portfolio Table 96. Novogene Recent Development Table 97. Roche Sequencing Solutions Company Information Table 98. Roche Sequencing Solutions Business Overview Table 99. Roche Sequencing Solutions Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio Table 101. Roche Sequencing Solutions Recent Development Table 102. SeqMatic Company Information Table 103. SeqMatic Business Overview Table 104. SeqMatic Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. SeqMatic Epigenetics NGS Service Product Portfolio Table 106. SeqMatic Recent Development Table 107. North America Epigenetics NGS Service Market Size by Type (2021-2026) & (US$ Million) Table 108. North America Epigenetics NGS Service Market Size by Type (2027-2032) & (US$ Million) Table 109. North America Epigenetics NGS Service Market Size by Application (2021-2026) & (US$ Million) Table 110. North America Epigenetics NGS Service Market Size by Application (2027-2032) & (US$ Million) Table 111. North America Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Epigenetics NGS Service Market Size by Country (2021-2026) Table 113. North America Epigenetics NGS Service Market Size by Country (2027-2032) Table 114. Europe Epigenetics NGS Service Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe Epigenetics NGS Service Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe Epigenetics NGS Service Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe Epigenetics NGS Service Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Epigenetics NGS Service Market Size by Country (2021-2026) Table 120. Europe Epigenetics NGS Service Market Size by Country (2027-2032) Table 121. China Epigenetics NGS Service Market Size by Type (2021-2026) & (US$ Million) Table 122. China Epigenetics NGS Service Market Size by Type (2027-2032) & (US$ Million) Table 123. China Epigenetics NGS Service Market Size by Application (2021-2026) & (US$ Million) Table 124. China Epigenetics NGS Service Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Epigenetics NGS Service Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia Epigenetics NGS Service Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia Epigenetics NGS Service Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia Epigenetics NGS Service Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Epigenetics NGS Service Market Size by Country (2021-2026) Table 131. Asia Epigenetics NGS Service Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa Epigenetics NGS Service Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Epigenetics NGS Service Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Epigenetics NGS Service Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Epigenetics NGS Service Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa Epigenetics NGS Service Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa Epigenetics NGS Service Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Epigenetics NGS Service Product Image Figure 2. Global Epigenetics NGS Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Epigenetics NGS Service Market Share by Type: 2025 VS 2032 Figure 4. DNA Methylation Sequencing Image Figure 5. Histone Modification Sequencing Image Figure 6. 3D Genome Sequencing Image Figure 7. Others Image Figure 8. Global Epigenetics NGS Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Epigenetics NGS Service Market Share by Application: 2025 VS 2032 Figure 10. Clinical Diagnostics Image Figure 11. Basic Research Image Figure 12. Drug Development Image Figure 13. Agricultural Breeding Image Figure 14. Others Image Figure 15. Global Epigenetics NGS Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 17. Global Epigenetics NGS Service Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Epigenetics NGS Service Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Epigenetics NGS Service Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Epigenetics NGS Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Epigenetics NGS Service Revenue Market Share by Type (2021-2032) Figure 24. Global Epigenetics NGS Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Epigenetics NGS Service Revenue Market Share by Application (2021-2032) Figure 26. North America Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 27. North America Epigenetics NGS Service Market Share by Type (2021-2032) Figure 28. North America Epigenetics NGS Service Market Share by Application (2021-2032) Figure 29. North America Epigenetics NGS Service Market Share by Country (2021-2032) Figure 30. United States Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 31. Canada Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 34. Europe Epigenetics NGS Service Market Share by Type (2021-2032) Figure 35. Europe Epigenetics NGS Service Market Share by Application (2021-2032) Figure 36. Europe Epigenetics NGS Service Market Share by Country (2021-2032) Figure 37. Germany Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 38. France Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 40. Italy Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 41. Russia Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 43. China Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 44. China Epigenetics NGS Service Market Share by Type (2021-2032) Figure 45. China Epigenetics NGS Service Market Share by Application (2021-2032) Figure 46. Asia Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 47. Asia Epigenetics NGS Service Market Share by Type (2021-2032) Figure 48. Asia Epigenetics NGS Service Market Share by Application (2021-2032) Figure 49. Asia Epigenetics NGS Service Market Share by Country (2021-2032) Figure 50. Japan Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 54. India Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 55. Australia Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Epigenetics NGS Service Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Epigenetics NGS Service Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Epigenetics NGS Service Market Share by Country (2021-2032) Figure 60. Brazil Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 65. UAE Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 67. Chile Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Sequencing
  • Histone Modification Sequencing
  • 3D Genome Sequencing
  • Others
Applications
  • Clinical Diagnostics
  • Basic Research
  • Drug Development
  • Agricultural Breeding
  • Others
Companies covered
  • Active Motif
  • Agilent
  • Zymo Research
  • Celemics
  • EpiGentek
  • GENEWIZ from Azenta
  • Thermo Fisher Scientific
  • GenomeScan
  • Hologic Diagenode
  • Illumina
  • Macrogen
  • Novogene
  • Roche Sequencing Solutions
  • SeqMatic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Epigenetics NGS Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Methylation Sequencing
  5. 1.2.3 Histone Modification Sequencing
  6. 1.2.4 3D Genome Sequencing
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Epigenetics NGS Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical Diagnostics
  11. 1.3.3 Basic Research
  12. 1.3.4 Drug Development
  13. 1.3.5 Agricultural Breeding
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Epigenetics NGS Service Growth Trends by Region
  17. 1.5.1 Global Epigenetics NGS Service Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Epigenetics NGS Service Market Size by Region (2021-2026)
  19. 1.5.3 Epigenetics NGS Service Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Epigenetics NGS Service Market Dynamics
  1. 2.1 Epigenetics NGS Service Industry Trends
  2. 2.2 Epigenetics NGS Service Industry Drivers
  3. 2.3 Epigenetics NGS Service Industry Opportunities and Challenges
  4. 2.4 Epigenetics NGS Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Epigenetics NGS Service Revenue by Company (2021-2026)
  2. 3.2 Global Epigenetics NGS Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Epigenetics NGS Service Key Company Head office and Area Served
  4. 3.4 Global Epigenetics NGS Service Company, Product Type & Application
  5. 3.5 Global Epigenetics NGS Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Epigenetics NGS Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Epigenetics NGS Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Epigenetics NGS Service Tier 1, Tier 2, and Tier 3
4 Epigenetics NGS Service Market by Type
  1. 4.1 Global Epigenetics NGS Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Epigenetics NGS Service Market Size by Type (2021-2032)
  3. 4.3 Global Epigenetics NGS Service Market Size Share by Type (2021-2032)
5 Epigenetics NGS Service Market by Application
  1. 5.1 Global Epigenetics NGS Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Epigenetics NGS Service Market Size by Application (2021-2032)
  3. 5.3 Global Epigenetics NGS Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Active Motif
  2. 6.1.1 Active Motif Company Information
  3. 6.1.2 Active Motif Business Overview
  4. 6.1.3 Active Motif Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Active Motif Epigenetics NGS Service Product Portfolio
  6. 6.1.5 Active Motif Recent Developments
  7. 6.2 Agilent
  8. 6.2.1 Agilent Company Information
  9. 6.2.2 Agilent Business Overview
  10. 6.2.3 Agilent Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Agilent Epigenetics NGS Service Product Portfolio
  12. 6.2.5 Agilent Recent Developments
  13. 6.3 Zymo Research
  14. 6.3.1 Zymo Research Company Information
  15. 6.3.2 Zymo Research Business Overview
  16. 6.3.3 Zymo Research Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Zymo Research Epigenetics NGS Service Product Portfolio
  18. 6.3.5 Zymo Research Recent Developments
  19. 6.4 Celemics
  20. 6.4.1 Celemics Company Information
  21. 6.4.2 Celemics Business Overview
  22. 6.4.3 Celemics Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Celemics Epigenetics NGS Service Product Portfolio
  24. 6.4.5 Celemics Recent Developments
  25. 6.5 EpiGentek
  26. 6.5.1 EpiGentek Company Information
  27. 6.5.2 EpiGentek Business Overview
  28. 6.5.3 EpiGentek Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 EpiGentek Epigenetics NGS Service Product Portfolio
  30. 6.5.5 EpiGentek Recent Developments
  31. 6.6 GENEWIZ from Azenta
  32. 6.6.1 GENEWIZ from Azenta Company Information
  33. 6.6.2 GENEWIZ from Azenta Business Overview
  34. 6.6.3 GENEWIZ from Azenta Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio
  36. 6.6.5 GENEWIZ from Azenta Recent Developments
  37. 6.7 Thermo Fisher Scientific
  38. 6.7.1 Thermo Fisher Scientific Company Information
  39. 6.7.2 Thermo Fisher Scientific Business Overview
  40. 6.7.3 Thermo Fisher Scientific Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio
  42. 6.7.5 Thermo Fisher Scientific Recent Developments
  43. 6.8 GenomeScan
  44. 6.8.1 GenomeScan Company Information
  45. 6.8.2 GenomeScan Business Overview
  46. 6.8.3 GenomeScan Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GenomeScan Epigenetics NGS Service Product Portfolio
  48. 6.8.5 GenomeScan Recent Developments
  49. 6.9 Hologic Diagenode
  50. 6.9.1 Hologic Diagenode Company Information
  51. 6.9.2 Hologic Diagenode Business Overview
  52. 6.9.3 Hologic Diagenode Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hologic Diagenode Epigenetics NGS Service Product Portfolio
  54. 6.9.5 Hologic Diagenode Recent Developments
  55. 6.10 Illumina
  56. 6.10.1 Illumina Company Information
  57. 6.10.2 Illumina Business Overview
  58. 6.10.3 Illumina Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Illumina Epigenetics NGS Service Product Portfolio
  60. 6.10.5 Illumina Recent Developments
  61. 6.11 Macrogen
  62. 6.11.1 Macrogen Company Information
  63. 6.11.2 Macrogen Business Overview
  64. 6.11.3 Macrogen Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Macrogen Epigenetics NGS Service Product Portfolio
  66. 6.11.5 Macrogen Recent Developments
  67. 6.12 Novogene
  68. 6.12.1 Novogene Company Information
  69. 6.12.2 Novogene Business Overview
  70. 6.12.3 Novogene Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Novogene Epigenetics NGS Service Product Portfolio
  72. 6.12.5 Novogene Recent Developments
  73. 6.13 Roche Sequencing Solutions
  74. 6.13.1 Roche Sequencing Solutions Company Information
  75. 6.13.2 Roche Sequencing Solutions Business Overview
  76. 6.13.3 Roche Sequencing Solutions Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio
  78. 6.13.5 Roche Sequencing Solutions Recent Developments
  79. 6.14 SeqMatic
  80. 6.14.1 SeqMatic Company Information
  81. 6.14.2 SeqMatic Business Overview
  82. 6.14.3 SeqMatic Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 SeqMatic Epigenetics NGS Service Product Portfolio
  84. 6.14.5 SeqMatic Recent Developments
7 North America
  1. 7.1 North America Epigenetics NGS Service Market Size (2021-2032)
  2. 7.2 North America Epigenetics NGS Service Market Size by Type
  3. 7.2.1 North America Epigenetics NGS Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Epigenetics NGS Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Epigenetics NGS Service Market Share by Type (2021-2032)
  6. 7.3 North America Epigenetics NGS Service Market Size by Application
  7. 7.3.1 North America Epigenetics NGS Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Epigenetics NGS Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Epigenetics NGS Service Market Share by Application (2021-2032)
  10. 7.4 North America Epigenetics NGS Service Market Size by Country
  11. 7.4.1 North America Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Epigenetics NGS Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Epigenetics NGS Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Epigenetics NGS Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Epigenetics NGS Service Market Size (2021-2032)
  2. 8.2 Europe Epigenetics NGS Service Market Size by Type
  3. 8.2.1 Europe Epigenetics NGS Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Epigenetics NGS Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Epigenetics NGS Service Market Share by Type (2021-2032)
  6. 8.3 Europe Epigenetics NGS Service Market Size by Application
  7. 8.3.1 Europe Epigenetics NGS Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Epigenetics NGS Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Epigenetics NGS Service Market Share by Application (2021-2032)
  10. 8.4 Europe Epigenetics NGS Service Market Size by Country
  11. 8.4.1 Europe Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Epigenetics NGS Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Epigenetics NGS Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Epigenetics NGS Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Epigenetics NGS Service Market Size (2021-2032)
  2. 9.2 China Epigenetics NGS Service Market Size by Type
  3. 9.2.1 China Epigenetics NGS Service Market Size by Type (2021-2026)
  4. 9.2.2 China Epigenetics NGS Service Market Size by Type (2027-2032)
  5. 9.2.3 China Epigenetics NGS Service Market Share by Type (2021-2032)
  6. 9.3 China Epigenetics NGS Service Market Size by Application
  7. 9.3.1 China Epigenetics NGS Service Market Size by Application (2021-2026)
  8. 9.3.2 China Epigenetics NGS Service Market Size by Application (2027-2032)
  9. 9.3.3 China Epigenetics NGS Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Epigenetics NGS Service Market Size (2021-2032)
  2. 10.2 Asia Epigenetics NGS Service Market Size by Type
  3. 10.2.1 Asia Epigenetics NGS Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Epigenetics NGS Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Epigenetics NGS Service Market Share by Type (2021-2032)
  6. 10.3 Asia Epigenetics NGS Service Market Size by Application
  7. 10.3.1 Asia Epigenetics NGS Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Epigenetics NGS Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Epigenetics NGS Service Market Share by Application (2021-2032)
  10. 10.4 Asia Epigenetics NGS Service Market Size by Country
  11. 10.4.1 Asia Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Epigenetics NGS Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Epigenetics NGS Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Epigenetics NGS Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Epigenetics NGS Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Epigenetics NGS Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Epigenetics NGS Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Epigenetics NGS Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Epigenetics NGS Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Epigenetics NGS Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Epigenetics NGS Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Epigenetics NGS Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Epigenetics NGS Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Epigenetics NGS Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Epigenetics NGS Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Epigenetics NGS Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Epigenetics NGS Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Epigenetics NGS Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst